117 related articles for article (PubMed ID: 32962737)
1. Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease.
Andrade-Campos MM; de Frutos LL; Cebolla JJ; Serrano-Gonzalo I; Medrano-Engay B; Roca-Espiau M; Gomez-Barrera B; Pérez-Heredia J; Iniguez D; Giraldo P
Orphanet J Rare Dis; 2020 Sep; 15(1):256. PubMed ID: 32962737
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease.
Andrade-Campos M; Alfonso P; Irun P; Armstrong J; Calvo C; Dalmau J; Domingo MR; Barbera JL; Cano H; Fernandez-Galán MA; Franco R; Gracia I; Gracia-Antequera M; Ibañez A; Lendinez F; Madruga M; Martin-Hernández E; O'Callaghan MDM; Del Soto AP; Del Prado YR; Sancho-Val I; Sanjurjo P; Pocovi M; Giraldo P
Orphanet J Rare Dis; 2017 May; 12(1):84. PubMed ID: 28468677
[TBL] [Abstract][Full Text] [Related]
3. Late-onset Myoclonic Seizure in a 78-year-old Woman with Gaucher Disease.
Yamaguchi-Takegami N; Takahashi A; Mitsui J; Sugiyama Y; Chikada A; Porto KJL; Takegami N; Sakuishi K; Ishiura H; Yamada K; Shimizu J; Tsuji S; Toda T
Intern Med; 2024 Mar; 63(6):861-865. PubMed ID: 37558486
[TBL] [Abstract][Full Text] [Related]
4. Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review.
Revel-Vilk S; Fuller M; Zimran A
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998334
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease in Gaucher disease patients: what's changing in the counseling and management of patients and their relatives?
Di Rocco M; Di Fonzo A; Barbato A; Cappellini MD; Carubbi F; Giona F; Giuffrida G; Linari S; Pession A; Quarta A; Scarpa M; Spada M; Strisciuglio P; Andria G
Orphanet J Rare Dis; 2020 Sep; 15(1):262. PubMed ID: 32967694
[TBL] [Abstract][Full Text] [Related]
6. Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease.
Dinur T; Istaiti M; Frydman D; Becker-Cohen M; Szer J; Zimran A; Revel-Vilk S
Orphanet J Rare Dis; 2020 Oct; 15(1):284. PubMed ID: 33050940
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of pregnancies in patients with Gaucher Disease: The experience of a center of excellence on rare metabolic Disease-Gaucher Disease, in Greece.
Komninaka V; Flevari P; Marinakis T; Karkaletsis G; Malakou L; Repa K
Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():181-187. PubMed ID: 33032100
[TBL] [Abstract][Full Text] [Related]
8. The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher disease.
Nascimbeni F; Lugari S; Andreone P; Carubbi F
Liver Int; 2021 Jan; 41(1):224-225. PubMed ID: 33091221
[No Abstract] [Full Text] [Related]
9. Desmoid-type fibromatosis in children. Clinical features, treatment response, and long-term follow-up.
Fortunati D; Kaplan J; López Martí J; Ponzone A; Innocenti S; Fiscina S; Cacciavillano W; Zubizarreta P; Rose A
Medicina (B Aires); 2020; 80(5):495-504. PubMed ID: 33048794
[TBL] [Abstract][Full Text] [Related]
10. VITREOUS HEMORRHAGE IN TYPE 3 GAUCHER DISEASE: AN ANGIOGRAPHIC AND PATHOLOGIC ANALYSIS.
Hua HU; Haghighi A; Shillingford N; Lee TC; Nagiel A
Retin Cases Brief Rep; 2022 Jul; 16(4):414-418. PubMed ID: 33017378
[TBL] [Abstract][Full Text] [Related]
11. Consequences of treatment for hemophagocytic lymphohistiocytosis in a patient with undiagnosed Gaucher disease Type 1.
Anderson HE; Taylor MRG
Am J Med Genet A; 2020 Dec; 182(12):2988-2993. PubMed ID: 32985097
[TBL] [Abstract][Full Text] [Related]
12. The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspective.
Elmonem MA; Belanger-Quintana A; Bordugo A; Boruah R; Cortès-Saladelafont E; Endrakanti M; Giraldo P; Grünert SC; Gupta N; Kabra M; Knerr I; Krämer J; Kuster A; Levtchenko E; Ngu LH; Rovira-Remisa MM; Sass JO; Sykut-Cegielska J; Tummolo A; van den Heuvel LP
Mol Genet Metab; 2020 Nov; 131(3):285-288. PubMed ID: 33004274
[TBL] [Abstract][Full Text] [Related]
13. Scoring system to facilitate diagnosis of Gaucher disease.
Mehta A; Rivero-Arias O; Abdelwahab M; Campbell S; McMillan A; Rolfe MJ; Bright JR; Kuter DJ
Intern Med J; 2020 Dec; 50(12):1538-1546. PubMed ID: 33174353
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Reliable Biomarker Profile for the Diagnosis of Gaucher Disease Type 1 Patients Using a Mass Spectrometry-Based Metabolomic Approach.
Menkovic I; Boutin M; Alayoubi A; Mercier FE; Rivard GÉ; Auray-Blais C
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114153
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic stem cell transplantation for treating severe lung involvement in Gaucher disease.
Lee FS; Yen HJ; Niu DM; Hung GY; Lee CY; Yeh YC; Chen PC; Chang SK; Yang CF
Mol Genet Metab Rep; 2020 Dec; 25():100652. PubMed ID: 33101978
[TBL] [Abstract][Full Text] [Related]
16. Optimization of Eliglustat-Based Glucosylceramide Synthase Inhibitors as Substrate Reduction Therapy for Gaucher Disease Type 3.
Wilson MW; Shu L; Hinkovska-Galcheva V; Jin Y; Rajeswaran W; Abe A; Zhao T; Luo R; Wang L; Wen B; Liou B; Fannin V; Sun D; Sun Y; Shayman JA; Larsen SD
ACS Chem Neurosci; 2020 Oct; 11(20):3464-3473. PubMed ID: 33035424
[TBL] [Abstract][Full Text] [Related]
17. Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia.
Motta I; Consonni D; Stroppiano M; Benedetto C; Cassinerio E; Tappino B; Ranalli P; Borin L; Facchini L; Patriarca A; Barcellini W; Lanza F; Filocamo M; Cappellini MD;
Sci Rep; 2021 Jan; 11(1):2594. PubMed ID: 33510429
[TBL] [Abstract][Full Text] [Related]
18. Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York.
Fierro L; Nesheiwat N; Naik H; Narayanan P; Mistry PK; Balwani M
Mol Genet Metab; 2021 Jan; 132(1):44-48. PubMed ID: 33353808
[TBL] [Abstract][Full Text] [Related]
19. Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment.
Weinreb NJ; Camelo JS; Charrow J; McClain MR; Mistry P; Belmatoug N;
Mol Genet Metab; 2021 Feb; 132(2):100-111. PubMed ID: 33485799
[TBL] [Abstract][Full Text] [Related]
20. Hematological manifestations and complications of Gaucher disease.
Revel-Vilk S; Szer J; Zimran A
Expert Rev Hematol; 2021 Apr; 14(4):347-354. PubMed ID: 33759681
[No Abstract] [Full Text] [Related]
[Next] [New Search]
